Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rintaro Hashizume

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Cell Reports|October 21, 2020
Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPGIlango Balakrishnan, Etienne Danis, Angela Pierce, et al.
Nature Neuroscience|August 11, 2015
EAG2 potassium channel with evolutionarily conserved function as a brain tumor targetXi Huang, Ye He, Adrian M Dubuc, et al.
The Journal of Clinical Investigation|April 17, 2025
Disruption of Ataxia-telangiectasia mutated kinase enhances radiation therapy efficacy in spatially-directed diffuse midline glioma modelsAvani Mangoli, Vennesa Valentine, Spencer Maingi, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Cell Reports|October 21, 2020
Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPGIlango Balakrishnan, Etienne Danis, Angela Pierce, et al.
Nature Neuroscience|August 11, 2015
EAG2 potassium channel with evolutionarily conserved function as a brain tumor targetXi Huang, Ye He, Adrian M Dubuc, et al.
The Journal of Clinical Investigation|April 17, 2025
Disruption of Ataxia-telangiectasia mutated kinase enhances radiation therapy efficacy in spatially-directed diffuse midline glioma modelsAvani Mangoli, Vennesa Valentine, Spencer Maingi, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
Pageof 9